New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
08:26 EDTGGenpact accepted payments for $302.6M from modified "Dutch Auction" offer
Genpact announced the final results of its modified "Dutch Auction" self-tender offer for the purchase of up to $300M in value of its common shares, which expired at 12:00 Midnight, New York City time, at the end of the day on April 2. Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, Genpact accepted for payment an aggregate of 17,292,842 common shares at a final purchase price of $17.50 per share, for an aggregate cost of approximately $302.6M, excluding fees and expenses relating to the tender offer. The shares accepted for purchase in the tender offer include shares accepted through Genpact's exercise of its right to upsize the tender offer by up to 2% of its outstanding shares.
News For G From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
16:08 EDTGGenpact boosts share repurchase program by $250M to $500M
Subscribe for More Information
16:07 EDTGGenpact sees 2016 adjusted EPS $1.40-$1.42, consensus $1.39
Subscribe for More Information
16:06 EDTGGenpact reports Q4 adjusted EPS 34c, consensus 31c
Subscribe for More Information
08:10 EDTGNASCO and Genpact announces partnership to reimagine US healthcare
NASCO and Genpact announced they will partner in an innovative effort to address the business operations needs of healthcare plans in the continually evolving U.S. healthcare market. NASCO and Genpact will transform health plan administration into a digitally-powered operating model that surrounds and extends NASCO's established, extremely efficient and scalable technology platform.
February 2, 2016
11:18 EDTGGenpact management to meet with Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use